Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Buddyboy20's Profile
Displaying 1-50 of 647 result(s).
CYDY CytoDyn Inc
06/26/2025 7:15:33 AM
Assuming that DSMB isn't manipulate (5)
CYDY CytoDyn Inc
06/26/2025 6:59:27 AM
I see it as the FDA still refuses t (13)
CYDY CytoDyn Inc
06/25/2025 9:17:55 PM
"I think our results in CRC trial s (14)
CYDY CytoDyn Inc
06/22/2025 5:15:27 PM
"Nobody knows but he’s been here
CYDY CytoDyn Inc
06/20/2025 8:13:04 PM
Reprogramming tumor cells with, non (7)
CYDY CytoDyn Inc
06/20/2025 5:17:49 PM
It looks like it's just another PD- (6)
CYDY CytoDyn Inc
06/11/2025 2:33:09 PM
"Setting the record straight for ne (6)
CYDY CytoDyn Inc
06/05/2025 11:24:40 AM
"Would LL help HIV patients if it c (7)
CYDY CytoDyn Inc
06/04/2025 9:41:37 AM
"Given the safety profile, based on (9)
CYDY CytoDyn Inc
05/27/2025 6:49:01 AM
I put Leronlimab PLS. Google gave m
CYDY CytoDyn Inc
05/26/2025 8:36:37 PM
"If Cytodyn or a partner were to pu (1)
CYDY CytoDyn Inc
05/26/2025 11:34:51 AM
Interesting read: Summary: Research (10)
CYDY CytoDyn Inc
05/21/2025 6:14:12 PM
I'm sure he is still on Leronlimab (6)
CYDY CytoDyn Inc
05/21/2025 5:47:28 PM
New update for the good Dr Chan: Dr (20)
CYDY CytoDyn Inc
05/18/2025 4:36:11 PM
It looks like Joe Biden needs Leron (5)
CYDY CytoDyn Inc
05/14/2025 8:59:24 AM
Does anybody remember this? "The fa (16)
CYDY CytoDyn Inc
05/13/2025 11:10:58 AM
In addition to the astounding possi (16)
CYDY CytoDyn Inc
05/06/2025 10:06:12 AM
From the December letter: "Third, w (11)
CYDY CytoDyn Inc
04/28/2025 11:22:48 AM
"To conclude, by leveraging an unco (10)
CYDY CytoDyn Inc
04/22/2025 7:21:55 AM
Good article about controlling over (9)
CYDY CytoDyn Inc
04/07/2025 8:59:16 AM
I was following a young woman's sto (30)
CYDY CytoDyn Inc
04/02/2025 7:46:29 PM
Interesting article that explains h (18)
CYDY CytoDyn Inc
03/28/2025 3:57:02 PM
"Glioblastoma outbreaks...wonder ho (18)
CYDY CytoDyn Inc
03/25/2025 10:40:39 AM
Casava Science gives up on their Al (8)
CYDY CytoDyn Inc
03/03/2025 10:27:39 AM
I am sorry to lead you into thinkin (4)
CYDY CytoDyn Inc
03/02/2025 4:44:09 PM
"Most docs understand CCR5 and the (7)
CYDY CytoDyn Inc
03/02/2025 2:56:54 PM
Yes sir!!! Ignorance and stupid rem (4)
CYDY CytoDyn Inc
03/02/2025 12:19:05 PM
It looks like the British haven't f (13)
CYDY CytoDyn Inc
02/28/2025 12:59:37 PM
I've never been able to tie that te (10)
CYDY CytoDyn Inc
02/26/2025 2:34:02 PM
While a lot of us have been around (17)
CYDY CytoDyn Inc
02/20/2025 3:40:58 PM
Most likely, they are refer to this (2)
CYDY CytoDyn Inc
02/19/2025 10:49:32 AM
Addition information on this. From (8)
CYDY CytoDyn Inc
02/18/2025 4:45:08 PM
Class action lawsuit filed against (2)
CYDY CytoDyn Inc
02/16/2025 10:24:05 AM
This is pretty amazing stuff! The U (15)
CYDY CytoDyn Inc
02/15/2025 10:56:01 AM
There's been a lot of speculation a (1)
CYDY CytoDyn Inc
02/14/2025 9:35:30 PM
The article points to type 1 diabet (5)
CYDY CytoDyn Inc
02/14/2025 8:38:30 PM
Citadel is shorting GSK. https://ww (3)
CYDY CytoDyn Inc
02/14/2025 2:23:52 PM
It looks like the new thing might b (8)
CYDY CytoDyn Inc
02/13/2025 11:09:35 AM
"Heart scarring, also known as myoc (13)
CYDY CytoDyn Inc
02/12/2025 7:57:19 AM
A pilot study, with a small populat (4)
CYDY CytoDyn Inc
02/09/2025 9:25:12 PM
Yet another paper that illuminates (13)
CYDY CytoDyn Inc
02/06/2025 7:40:57 PM
I'm guessing that you're in disagre (1)
CYDY CytoDyn Inc
02/06/2025 5:15:09 PM
The last hour of trading, during th (8)
CYDY CytoDyn Inc
02/06/2025 8:55:52 AM
If I had a foundation, in my name, (5)
CYDY CytoDyn Inc
02/05/2025 10:52:35 AM
One can only wonder what Dr Chan's (2)
CYDY CytoDyn Inc
02/05/2025 9:20:44 AM
For a little more than a week, ther (3)
CYDY CytoDyn Inc
02/02/2025 10:10:33 PM
Every time I see a St Jude advertis (14)
CYDY CytoDyn Inc
02/01/2025 11:05:49 AM
"My Fidelity and E*trade accounts b (6)
CYDY CytoDyn Inc
01/25/2025 12:37:22 PM
It could as late as Tuesday Feb 5, (4)
CYDY CytoDyn Inc
01/21/2025 6:25:49 AM
Here is a link to an article, in Th (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Hexagon Purus Presents Q2 Results: Key Details and Innovations
  • Capgemini's New AI Framework to Enhance Business Effectiveness
  • Strong Growth in Passenger Numbers for AS Tallink Grupp
  • Northern 3 VCT PLC Announces Share Repurchase Program Details
  • EDF Successfully Raises ¥75.8 Billion with New Bond Offering
  • Stolt-Nielsen Limited Shows Resilience Amid Market Challenges
  • Leadership Changes at Huhtamaki to Drive Sustainability Forward
  • Northern 2 VCT PLC Completes Significant Share Buyback
  • NBPE Share Buyback: A Strategic Move for Investors
  • Northern Venture Trust PLC Engages in Strategic Share Buyback
  • Foresight Group Holdings Expands Share Buyback Program
  • Geopolitical Shifts Challenge Dollar's Dominance on Global Stage
  • Andrés Iniesta Teams Up with MelBet Empowering Fair Play
  • Queen Máxima Leads Global Finance & Technology Network Initiative
  • Systemair Welcomes New Leadership with Robert Larsson as CEO
  • Planisware Expands Global Footprint with New Office in Seoul
  • Fingerprint Cards AB Announces Key Reverse Share Split Dates
  • AS Tallink Grupp Highlights Passenger Transport Growth in June
  • Leadership Transition at Huhtamaki Enhances Executive Team
  • Stolt-Nielsen Ltd Achieves Solid Performance Amid Challenges
  • Insights on Leading Thermal Camera Players Enhancing Market Reach
  • Volta Labs Strengthens Nordic Ties with Callisto Installation
  • Walker Lane Resources Outlines Positive Developments in Geophysical Studies
  • Diversified Energy Company PLC Announces Share Buyback Activity
  • SalMar ASA Gains Approval for Major Green Bond Issues
  • Nixol Weight Loss Capsules: A Natural Solution for Wellness
  • MIRA Pharmaceuticals' Innovative Pain Relief Drug Mira-55 Gains Attention
  • Achieving Wealth through BTC Miner: Cloud Mining Simplified
  • Anduril Industries: Leading the Charge in Defense Technology
  • Insights into Novartis' Cosentyx and GCAptAIN Study Findings
  • Novotech: Leading the Charge in Biotech Contract Research
  • Azentio Appoints New ERP President to Drive Innovation Forward
  • Unlock Daily Income with NR7 Miner's Innovative Cloud Mining
  • Explore EQT AB's Impressive Half-Year Performance Report
  • Novartis' GCAptAIN Study Shows Need for Further Research
  • Pluxee Achieves Strong Organic Growth in Third Quarter 2025
  • Pluxee Achieves Impressive Organic Revenue Growth in Q3 2025
  • Karolinska Development Update on OG-6219 Drug Candidate
  • Christina Lake Cannabis Delays Annual Financial Statements Until July
  • Impact of US Strikes on Iran's Nuclear Program Estimate Expanded
  • Introducing the Innovative Bond Ring: A Game Changer in Wearable Tech
  • Understanding Centene's Dramatic Decline: Key Factors Revealed
  • The Interconnected Growth of Bitcoin and GlobalCurrency Trends
  • Wei Zhou's Influence in Global Venture Capital Recognized
  • DMG Blockchain Solutions' June Operational Insights Revealed
  • The Big Beautiful Bill: A Bold Agenda for All Americans
  • Unlock Crypto Wealth with TWL Miner’s Mobile Cloud App
  • Celebrating Financial Excellence: MoneyHero's Best-Of Awards
  • Bitcoin's Surge Sparks Market Optimism for Altcoins Ahead
  • Legal Updates for Investors in Hims & Hers Health, Inc.
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site